Vitamin C Deficiency in Cancer Patients, Mayland,Bennett & Allan, Palliat. Med. 2005; 19: 17-20.
High-Dose Vitamin C Selectively
Kills Cancer Cells, Levine, et al., Proc. Natl. Acad. Sciences USA, 2005; 102: 13604-13609.
Intravenous Ascorbate as a Tumor
Cytotoxic Chemotheraeutic Agent, Riordan, et al., Med. Hypotheses 1995; 44: 207-213.
Prolonged Survival linked to Intravenous
Vitamin C Seen in Three Cancer Patients, Levine, et al, Can. Med. Assoc. J., 2006; 174: 937-942.
Changes of Terminal Cancer Patients’
Health-related Quality of Life After High Dose Vitamin C Administration, Yeom, Jung & Song, J. Korean Med Sci 2007; 22 (1):
7-11.
Intravenously Administered Vitamin C as a Cancer Therapy: Three Cases, Padayatty, Riordan, Hewitt, et al., CMAJ 2006;
174 (7): 937-942.
A Pilot Clinical Study of Continuous Intravenous Ascorbate in Terminal Cancer Patients, Riordan, Casciari,
Gonzalez, et al., P R Health Sci J 2005; 24 (4): 269-276.
Innovation vs. Quality Control: An ‘Unpublishable’Clinical Trial
of Supplemental Ascorbate in Incurable Cancer, Cameron & Campbell, Med Hypotheses 1991; 36 (3): 185-189.
Reticulum Cell Sarcoma:
Two Complete ‘Spontaneous’ Regressions, in Response to High-dose Ascorbic Acid Therapy. A Report on Subsequent Progress,
Changes of Terminal Cancer Patients’ Health-related Quality of
Life After High Dose Vitamin C Administration, Yeom, Jung & Song, J. Korean Med Sci 2007; 22 (1): 7-11.
Supplemental
Ascorbate in the Supportive Treatment of Cancer: Prolongation of Survival Times in Terminal Human Cancer, Cameron & Pauling, Proc. Natl Acad Sci
Vitamin C Inhibits p53-induced Replicative Senescence Through Suppression
of ROS Production and p38 MAPK Activity, Kim, Jin, Lee, et al., Biochem Pharmacol. 2008; 22 (5): 651-655.
Pharmacologic Ascorbic
Acid Concentrations Selectively Kill Cancer Cells: Action as a Pro-drug to Deliver Hydrogen Peroxide to Tissues, Chen, Espey, Krishna,
et al., Proc. Natl. Acad. Sci. U S A 2005; 102 (38): 13604-13609.
Vitamin C Pharmacokinetics: Implications for Oral and Intravenous
Use, Padayatty, Sun, Wang, et al., Ann. Intern. Med. 2004; 140 (7): 533-537.
Ascorbate in Pharmacologic Concentrations
Selectively Generates Ascorbate Radical and Hydrogen Peroxide in Extracellular Fluid in vivo, Chen, Espey, Sun, et al., Proc. Natl.
Acad. Sci U S A 2007; 104 (21): 8749-8754.
Phase I Clinical Trial of I.V. Ascorbic Acid in Advanced Malignancy, Hoffer, Levine,
Assouline, et al., Ann. Oncol. 2008; [Epub ahead of print]
Emerging Role of Ascorbic Acid in the Management of Advanced Breast
Carcinoma as a Chemosensitizer, Goel, Agarwal, Mandal, et al., Asian J. Surg. 1999; 22: 333-336.
In vivo Effect of Ascorbic Acid
on Enhancement of Human Natural Killer Cell Activity, Vojdani & Ghoneum, Nutr. Res.1993; 13: 753-754.
Enhancement of
Human Natural Killer Cytotoxic Activity by Vitamin C in Pure and Augmented Formulations, Vojdani & Namatalla, J. Nutr. Environ.
Med. 1997; 7 (3): 187-195.